SymBio Pharmaceuticals Limited announced earnings results for the six months ended June 30, 2021. For the six months, the company reported net sales of JPY 3,146,608,000 compared to JPY 1,360,648,000 a year ago. Operating loss was JPY 194,941,000 compared to JPY 1,839,942,000 a year ago. Loss was JPY 205,560,000 or JPY 5.37 per share compared to JPY 1,884,976,000 or JPY 62.47 per share a year ago.